Today, KEI hosted the first talk in a series of seminars on drug pricing. The seminar, conducted via video conference, focused on the Canadian approach to drug pricing. Each seminar in the series is intended to contribute to the discussion on drug pricing and how we can improve affordability and access to medicines. Paul Grootendorst began with a presentation (the slides are available here), before opening up the discussion to questions from those participating in the video conference.
The seminar was recorded and is available to view via YouTube below:
Paul Grootendorst is the Director of the Division of Social and Administrative Pharmacy in the Leslie Dan Faculty of Pharmacy at the University of Toronto. He is also an associate professor in the Faculty of Pharmacy and the School of Public Policy and Governance at the University of Toronto and an adjunct associate professor in the Department of Economics at McMaster University. Paul is also an associate editor of Health Economics.
He researches the effects of changes in financing health care and remuneration of health care providers on the behaviour of consumers and producers in the healthcare system. He is interested in interactions between brand and generic drug firms and is currently working on an evaluation of the system of reference pricing of anti-hypertensive and nitrate medicines introduced in British Columbia; and effects of patient cost sharing for prescription medicines on use of drugs and other health services using both administrative health claims and health survey data; effects of patent term extension on R&D activity and drug expenditures; and effects of physician expenditure caps on physician labour supply and service patterns
Link to personal page: http://individual.utoronto.ca/grootendorst/